Inhalac 400
Dry powder inhalants are often used in the pulmonary route of administration. Its advantages include excellent ease of use, small size for portability, and no precise fit (relative to aerosol) between device excitation and patient breathing. In addition, because it does not contain Freon, it is more environmentally friendly. In use and storage, solid dosage forms have better physicochemical stability. Dry powder inhalants generally consist of a device, drugs and auxiliaries. Additives are added to ensure a smooth production process. Therefore, the particle properties of powders related to the process are important factors that need to be paid attention to in the design of prescriptions.
InhaLac® 400 is an ultra-fine powdered lactose monohydrate, with a typical median value of 8 microns
next item: Inhalac 70





关闭返回